Literature DB >> 15355808

[Fast diagnostic tests in the management of group A beta-heamolytic streptococcal pharyngitis].

F Chiadmi1, J Schlatter, B Mounkassa, P Ovetchkine, N Vermerie.   

Abstract

OBJECTIVE: Routine clinical diagnosis of Streptococcus pyogenes in pharyngitis is not always easy. The use in common practice of rapid diagnosis test (RDT), might offer a best control of the antibiotic treatments. The aim of this study is to present seven rapid diagnosis tests, to assess their feasibility and finally to determine the bacteriological correlation.
METHOD: We propose to compare the results obtained with seven RDT, and to assess their interest in medical diagnosis for group A streptococcus pharyngitis. A prospective study was conducted for three months, a RDT was performed for children (n=75) between eight and fourteen years old presenting acute pharyngitis. Several throat sampling were performed to order cultures.
RESULTS: The group A streptococcus was isolated in 33% (n=25) of throat sampling. Comparing cultures results, and for all studied tests, we obtained comparable performances with manufacturer data, specificity upper than 94% and sensitivity upper than 88%.
CONCLUSION: All assessed RDT may offer to physicians a decision-making tool for rapid diagnosis. However, because of its complexity, the agglutination test can be used only in pathology laboratories.

Entities:  

Mesh:

Year:  2004        PMID: 15355808

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  2 in total

Review 1.  Rapid antigen detection test for group A streptococcus in children with pharyngitis.

Authors:  Jérémie F Cohen; Nathalie Bertille; Robert Cohen; Martin Chalumeau
Journal:  Cochrane Database Syst Rev       Date:  2016-07-04

Review 2.  Rapid antigen group A streptococcus test to diagnose pharyngitis: a systematic review and meta-analysis.

Authors:  Emily H Stewart; Brian Davis; B Lee Clemans-Taylor; Benjamin Littenberg; Carlos A Estrada; Robert M Centor
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.